{"anticipatedPostingDate":"2030-10","denomUnitsSelected":"Participants","description":"Blood samples will be collected for PK analysis of Pomalidomide in combination with belantamab mafodotin and dexamethasone.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 473 weeks","title":"Area Under Plasma Concentration-time Curve (AUC) From Time 0 to End of the Dosing Interval [AUC (0-tau)] for Pomalidomide","type":"SECONDARY"}